Recall: D-0757-2026

Class II - Potentially Harmful

Class IIClassification

2026-07-29Initiated

OngoingStatus

Apollo Care, LLCFirm

Product

SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.

Reason

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Distribution

Nationwide within the U.S

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.